CARISMA Therapeutics • CARM
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Steven Kelly$67.7M
Market Cap • 01/05/20242008
(há 16 anos)
2023
(1 year ago)
NASDAQ
Listagem
Philadelphia
Sede • PennsylvaniaValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CARMSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.